BlackRock’s Shuttle Pharmaceuticals SHPH Stock Holding History

BlackRock’s Portfolio SHPH Stock Details SHPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-154	Closed	-$1.41M	–	5837
2022 Q3	$1.41M	Buy	+154	New	+$6.27M	﹤0.01%	4351

Other funds holding SHPH

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock's SHPH Position: Q4 2022 in Review

BlackRock sold out of Shuttle Pharmaceuticals (SHPH) in Q4 2022, closing a stake of 154 shares — an estimated $1.41M sold.

BlackRock first reported a position in SHPH in Q3 2022 and held it in 1 quarter. The position peaked at $1.41M in Q3 2022. 8 funds tracked by Wall St. Rank hold SHPH as of Q4 2022.

BlackRock reported no remaining Shuttle Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
BlackRock sold 154 Shuttle Pharmaceuticals shares in Q4 2022, an estimated $1.41M.
BlackRock first reported a position in Shuttle Pharmaceuticals in Q3 2022 and held it in 1 quarter.
BlackRock's Shuttle Pharmaceuticals position peaked at $1.41M in Q3 2022.
8 funds tracked by Wall St. Rank held Shuttle Pharmaceuticals as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.